Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Gulf War Illness (GWI), a chronic multisymptom health problem, afflicts ~30% of veterans served in the first GW. Impaired brain function is among the most significant symptoms of GWI, which is typified by persistent cognitive and mood impairments, concentration problems, headaches, chronic fatigue, and musculoskeletal pain. This review aims to discuss findings from animal prototypes and veterans with GWI on mechanisms underlying its pathophysiology and emerging therapeutic strategies for alleviating brain dysfunction in GWI. Animal model studies have linked brain impairments to incessantly elevated oxidative stress, chronic inflammation, inhibitory interneuron loss, altered lipid metabolism and peroxisomes, mitochondrial dysfunction, modified expression of genes relevant to cognitive function, and waned hippocampal neurogenesis. Furthermore, the involvement of systemic alterations such as the increased intensity of reactive oxygen species and proinflammatory cytokines in the blood, transformed gut microbiome, and activation of the adaptive immune response have received consideration. Investigations in veterans have suggested that brain dysfunction in GWI is linked to chronic activation of the executive control network, impaired functional connectivity, altered blood flow, persistent inflammation, and changes in miRNA levels. Lack of protective alleles from Class II HLA genes, the altered concentration of phospholipid species and proinflammatory factors in the circulating blood have also been suggested as other aiding factors. While some drugs or combination therapies have shown promise for alleviating symptoms in clinical trials, larger double-blind, placebo-controlled trials are needed to validate such findings. Based on improvements seen in animal models of GWI, several antioxidants and anti-inflammatory compounds are currently being tested in clinical trials. However, reliable blood biomarkers that facilitate an appropriate screening of veterans for brain pathology need to be discovered. A liquid biopsy approach involving analysis of brain-derived extracellular vesicles in the blood appears efficient for discerning the extent of neuropathology both before and during clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“Chronic neuroinflammation typically leads to degradation and reduction of neural tissue volume and induces a leaky BBB, which allows the passage of proinflammatory cytokines into the circulating blood and result in immune modulation (Finneran & Nash, 2019; Heneka et al., 2015).”
BackgroundLong-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120
The Cognitive Neuroscience of Working Memory
D'Esposito, M., & Postle, B. R. (2015) · Annual Review of Psychology · doi:10.1146/annurev-psych-010814-015031 · Cited by 1,653
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour
Snyder, J. S., Soumier, A., Brewer, M., Pickel, J., & Cameron, H. A. (2011) · Nature · doi:10.1038/nature10287 · Cited by 1,473
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Kempermann, G., Gast, D., & Gage, F. H. (2002) · Annals of Neurology · doi:10.1002/ana.10262 · Cited by 889
Chronic Multisymptom Illness Affecting Air Force Veterans of the Gulf War
Fukuda, K. (1998) · JAMA · doi:10.1001/jama.280.11.981 · Cited by 729 · cited 1×
“mood, and altered cognition, and musculoskeletal pain (Fukuda et al., 1998).”
BackgroundDiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05327blu · Cited by 564 · cited 1×
“Ketamine, an FDA-approved drug for treatment-resistant depression (Kaufman, 2019), is effective in patients with major depression and suicidal ideation (DiazGranados et al., 2010).”
BackgroundTiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558 · cited 2×
“Improved cognitive and mood function in GWI animals receiving CUR was associated with increased neurogenesis in the hippocampus not only in the last week of treatment but also several months after treatment, consistent with the ability of CUR to increase neurogenesis through activation of canonical Wnt/β-catenin signa…”
BackgroundDepression and Hippocampal Neurogenesis: A Road to Remission?
Eisch, A. J., & Petrik, D. (2012) · Science · doi:10.1126/science.1222941 · Cited by 516
The new life of a centenarian: signalling functions of NAD(P)
Berger, F. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.01.007 · Cited by 489
Rahimifard, M., Maqbool, F., Moeini-Nodeh, S., Niaz, K., Abdollahi, M., Braidy, N., Nabavi, S. M., & Nabavi, S. F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.02.004 · Cited by 481 · cited 1×
“, 2017) through modulation of distinct transcription factors, inhibition of TLR4-MAPK/NF-κB pathway, and activation of ERK1/2 and p38 signaling pathway (Rahimifard et al., 2017; Shi et al., 2015; Ullah et al., 2017).”
BackgroundKorotkova, T., Fuchs, E. C., Ponomarenko, A., von Engelhardt, J., & Monyer, H. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.017 · Cited by 480
Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D. L., Zavala, E., Zhang, Y., Moritoh, K., O’Connell, J. F., Baptiste, B. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718819115 · Cited by 472 · cited 2×
“The rationale underlying such approach is that NR administration in animal models of neurodegeneration had reduced inflammation, glial activation and cognitive dysfunction through sirtuin-1 (Sirt1)-mediated deacetylation of the NF-κB pathway (Chen et al., 2018; Hou et al., 2018), and both NAD and Sirt1 levels are decr…”
BackgroundSolleiro-Villavicencio, H., & Rivas-Arancibia, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00114 · Cited by 463
Depression: an inflammatory illness?: Figure 1
Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392
Chronic peripheral inflammation, hippocampal neurogenesis, and behavior
Chesnokova, V., Pechnick, R. N., & Wawrowsky, K. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.01.017 · Cited by 299
Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
McQuade, A., & Blurton-Jones, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.045 · Cited by 244
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E
Spector, R., & Johanson, C. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04773.x · Cited by 175
Schwaller, B., Tetko, I. V., Tandon, P., Silveira, D. C., Vreugdenhil, M., Henzi, T., Potier, M.-C., Celio, M. R., & Villa, A. E. P. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.006 · Cited by 169 · cited 1×
“For example, reduced numbers of PV+ and NPY+ interneurons affect network properties, which can result in hippocampal hyperexcitability (Andrioli, Alonso-Nanclares, Arellano, & DeFelipe, 2007; Schwaller et al., 2004; Sperk, Hamilton, & Colmers, 2007) and cognitive dysfunction (Korotkova, Fuchs, Ponomarenko, von Engelha…”
Donta, S. T., Clauw, D. J., Engel, C. C., Guarino, P., Peduzzi, P., Williams, D. A., Skinner, J. S., Barkhuizen, A., Taylor, T., Kazis, L. E., et al. (2003) · JAMA · doi:10.1001/jama.289.11.1396 · Cited by 160 · cited 3×
“Cognitive behavioral therapy—A study by Donta and colleagues compared the efficacy of cognitive-behavioral therapy (CBT), aerobic exercise, and the combination of CBT and exercise for alleviating the symptoms of GWI in veterans (Donta et al., 2003).”
BackgroundMethodMore Is Less: A Disinhibited Prefrontal Cortex Impairs Cognitive Flexibility
Gruber, A. J., Calhoon, G. G., Shusterman, I., Schoenbaum, G., Roesch, M. R., & O'Donnell, P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4623-10.2010 · Cited by 160
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Merali, Z., Levac, C., & Anisman, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01827-9 · Cited by 157
Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus.
Andrioli, A., Alonso-Nanclares, L., Arellano, J. I., & DeFelipe, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.029 · Cited by 147
Bassani, T. B., Turnes, J. M., Moura, E. L. R., Bonato, J. M., Cóppola-Segovia, V., Zanata, S. M., Oliveira, R. M. M. W., & Vital, M. A. B. F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.014 · Cited by 134 · cited 1×
“Furthermore, CUR treatment reduced astrocyte hypertrophy and activated microglia in the hippocampus, which is not surprising as CUR is well known to mediate antiinflammatory effects in neurodegenerative and neuroinflammatory diseases (Bassani et al., 2017; Ullah et al., 2017) through modulation of distinct transcripti…”
BackgroundThe Brain-Enriched MicroRNA miR-9-3p Regulates Synaptic Plasticity and Memory
Sim, S.-E., Lim, C.-S., Kim, J.-I., Seo, D., Chun, H., Yu, N.-K., Lee, J., Kang, S. J., Ko, H.-G., Choi, J.-H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-16.2016 · Cited by 116 · cited 1×
“On the other hand, higher expression of miR-9–3p in the START group likely beneficial, as this miRNA is involved in facilitating long-term potentiation, synaptic plasticity, and memory formation (Sim et al., 2016).”
BackgroundShi, X., Zheng, Z., Li, J., Xiao, Z., Qi, W., Zhang, A., Wu, Q., & Fang, Y. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.045 · Cited by 108 · cited 1×
“, 2017) through modulation of distinct transcription factors, inhibition of TLR4-MAPK/NF-κB pathway, and activation of ERK1/2 and p38 signaling pathway (Rahimifard et al., 2017; Shi et al., 2015; Ullah et al., 2017).”
BackgroundJimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 103
Investigations into the involvement of NMDA mechanisms in recognition memory
Warburton, E. C., Barker, G. R. I., & Brown, M. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.013 · Cited by 98
Post-traumatic stress disorder: a right temporal lobe syndrome?
Engdahl, B., Leuthold, A. C., Tan, H.-R. M., Lewis, S. M., Winskowski, A. M., Dikel, T. N., & Georgopoulos, A. P. (2010) · Journal of Neural Engineering · doi:10.1088/1741-2560/7/6/066005 · Cited by 97
Beilharz, J. E., Kaakoush, N. O., Maniam, J., & Morris, M. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.151 · Cited by 93
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.033 · Cited by 86 · cited 2×
“The rationale underlying such approach is that NR administration in animal models of neurodegeneration had reduced inflammation, glial activation and cognitive dysfunction through sirtuin-1 (Sirt1)-mediated deacetylation of the NF-κB pathway (Chen et al., 2018; Hou et al., 2018), and both NAD and Sirt1 levels are decr…”
BackgroundNeuropeptides and hippocampal neurogenesis
Zaben, M. J., & Gray, W. P. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.002 · Cited by 75
Ruggieri, S., Orsomando, G., Sorci, L., & Raffaelli, N. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.02.021 · Cited by 71
The profile of cognitive impairments in chronic ketamine users
Ke, X., Ding, Y., Xu, K., He, H., Wang, D., Deng, X., Zhang, X., Zhou, Y., Zhou, C., Liu, Y., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.050 · Cited by 67
Seth, R. K., Kimono, D., Alhasson, F., Sarkar, S., Albadrani, M., Lasley, S. K., Horner, R., Janulewicz, P., Nagarkatti, M., Nagarkatti, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.05.006 · Cited by 55 · cited 1×
“Additional studies demonstrated that butyrate or TLR4 inhibitor treatment could restore gut homeostasis through decreased expression of claudin-2, and reduced activation of TLR4 and enteric glial cells (Kimono et al., 2019; Seth et al., 2018).”
BackgroundDonta, S. T., Engel, C. C., Collins, J. F., Baseman, J. B., Dever, L. L., Taylor, T., Boardman, K. D., Kazis, L. E., Martin, S. E., Horney, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00006 · Cited by 54
Progression of intervention-focused research for Gulf War illness
Chester, J. E., Rowneki, M., Van Doren, W., & Helmer, D. A. (2019) · Military Medical Research · doi:10.1186/s40779-019-0221-x · Cited by 38
Nakamura, Y., Lipschitz, D. L., Donaldson, G. W., Kida, Y., Williams, S. L., Landward, R., Glover, D. W., West, G., & Tuteja, A. K. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000469 · Cited by 31
Coping with Medically Unexplained Physical Symptoms: the Role of Illness Beliefs and Behaviors
Sullivan, N., Phillips, L. A., Pigeon, W. R., Quigley, K. S., Graff, F., Litke, D. R., Helmer, D. A., Rath, J. F., & McAndrew, L. M. (2019) · International Journal of Behavioral Medicine · doi:10.1007/s12529-019-09817-z · Cited by 25
Cited by
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
“Reliable blood biomarkers need to be discovered for GWI [90].”
BackgroundInfluentialRibeiro, A. C. R., Jahr, F. M., Hawkins, E., Kronfol, M. M., Younis, R. M., McClay, J. L., & Deshpande, L. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119765 · Cited by 30
Adaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness
Nkiliza, A., Joshi, U., Evans, J. E., Ait-Ghezala, G., Parks, M., Crawford, F., Mullan, M., & Abdullah, L. (2021) · Neuroscience Insights · doi:10.1177/26331055211018458 · Cited by 15
Metadata
- Authors
- Dickey, B., Madhu, L. N., & Shetty, A. K.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 220
- Pages
- 107716
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W3094063713
- Cited by
- 73
- References
- 43
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.